# Pliant Therapeutics, Inc.: Form 8-K, filed Jul 13, 2026

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2026-07-13
- Accepted by EDGAR: Jul 13, 2026, 20:25 ET
- Period: 2026-07-09
- Accession: 0001746473-26-000107
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000174647326000107/plrx-20260709.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000174647326000107/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000174647326000107/plrx-20260709.htm

Filed Jul 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001746473-26-000107. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.